$200m for personalised medicine
Luxembourg – The government of Luxembourg has tapped three prominent US biomedical science organisations to accelerate the country’s pace of innovation in the biosciences by developing a biobank, to conduct two major projects to advance personalized medicine, and to study the effectiveness of early-detection lung cancer diagnostics. Early in June, Luxembourg announced that in order to advance biosciences innovation in the country, it had solicited the help of the Partnership for Personalized Medicine led by nobel laureate Lee Hartwell (Hutchinson Cancer Research, Seattle), Leroy Hood (Institute for Systems Bio-logy, Seattle) and Jeffrey Trent (head of Arizona’s Translational Genomics Research Institute (TGen). TGen will guide Luxembourg’s biobanking effort, the ISB will help create the Center for Systems Biology Luxembourg, while the PPM will take the lead on the lung cancer diagnostic project. Luxembourg’s government is investing US$200m in the initiative in the hopes of advancing personalized medicine for its own people and to spur international collaboration. Some participants also say that the effort could serve as a model for other governments looking to reduce research costs and gain access to other researchers’ data.